Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination (NCT07294950)
Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: a Randomized Controlled Trial Comparing Gradual Dose Reduction With Immediate Treatment Cessation.
🩺 Plain-English Summary (8th-Grade Level)
Semaglutide is a medication from the class of drugs called glucagon-like peptide-1 agonists that promote weight loss. There is little clinical data on the best strategy to achieve weight maintenance following weight reduction induced by semaglutide. For people who need to discontinue treatment, it is unknown whether the weight regain, its accompanied health benefits could be ameliorated with a gradual reduction in semaglutide. The investigators will study if a gradual reduction of semaglutide is associated with different heart risk profile and hormones involved in energy regulation as compared to immediate treatment cessation.
Who can join: Review the eligibility criteria below.
Location: Leadership Sinai Centre for Diabetes — Toronto, Ontario
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Leadership Sinai Centre for Diabetes — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: +1 4165864800 ext 7628
Email: caroline.kramer@sinaihealth.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity (Disorder)
- Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals. — Prairie View, Texas
- Iron Metabolism in Obesity — San Pedro Garza García, Nuevo León
- Continuous Glucose Monitoring in Metabolic Surgery — Baton Rouge, Louisiana
- Healthy Living Anson Study — Chapel Hill, North Carolina
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity — Hamilton, Ontario
- Repeated Far Infrared Sauna Bathing in Adults With Obesity — Eugene, Oregon
Explore by condition: All Obesity (Disorder) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.